These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Significance of human beta-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections. Yanagi S; Ashitani J; Imai K; Kyoraku Y; Sano A; Matsumoto N; Nakazato M Clin Microbiol Infect; 2007 Jan; 13(1):63-9. PubMed ID: 17184289 [TBL] [Abstract][Full Text] [Related]
17. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients. Ionescu A; Meitert E; Vasiliu S; Meitert T; Sima F; Savulian C; Milicescu S Arch Roum Pathol Exp Microbiol; 1981; 40(4):323-32. PubMed ID: 6803737 [No Abstract] [Full Text] [Related]
18. Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections. Maciá MD; Mena A; Borrell N; Pérez JL; Oliver A Antimicrob Agents Chemother; 2007 Dec; 51(12):4531-2. PubMed ID: 17893154 [No Abstract] [Full Text] [Related]
19. Determination of type specific IgG Pseudomonas antibodies by the ELISA test after administration of the anti Pseudomonas aeruginosa vaccine. Meitert T; Meitert E; Pencu E; Tonciu M Arch Roum Pathol Exp Microbiol; 1984; 43(1):53-60. PubMed ID: 6442132 [No Abstract] [Full Text] [Related]
20. [Trend of resistant Pseudomonas aeruginosa from field of clinical laboratory medicine]. Oguri T; Misawa S; Igari J Nihon Rinsho; 1991 Oct; 49(10):2367-72. PubMed ID: 1749094 [No Abstract] [Full Text] [Related] [Next] [New Search]